Juan Frias
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Juan Pablo Frias is currently Director at T1D Exchange.
Formerly, Dr. Frias was Chief Executive Officer at National Research Institute from 2013 to 2020.
Dr. Frias was President & Chief Executive Officer at NRI Clinical Research LLC.
Dr. Frias was Medical Director at Velocity Clinical Research, Inc. Dr. Frias was Chief Medical Officer & Head-Diabetes at Biomea Fusion, Inc. Dr. Frias was Chief Medical Officer at Johnson & Johnson from 2007 to 2010.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
National Research Institute
National Research Institute BiotechnologyHealth Technology Provides innovative therapies for health care | Directeur Général | 01/10/2020 |
| JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | 01/07/2010 |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Operates as a clinical research sites | Directeur Technique/Scientifique/R&D | - |
| BIOMEA FUSION, INC. | Directeur Technique/Scientifique/R&D | - |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology Owns and operates clinical research center | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
National Research Institute
National Research Institute BiotechnologyHealth Technology Provides innovative therapies for health care | Health Technology |
NRI Clinical Research LLC
NRI Clinical Research LLC BiotechnologyHealth Technology Owns and operates clinical research center | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Health Technology |
Velocity Clinical Research, Inc.
Velocity Clinical Research, Inc. Internet Software/ServicesTechnology Services Operates as a clinical research sites | Technology Services |
Biomea Fusion, Inc.
Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national